{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T09:13:42Z","timestamp":1793092422824,"version":"4.5.0"},"reference-count":114,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infectious Disease Clinics of North America"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.idc.2020.10.004","type":"journal-article","created":{"date-parts":[[2020,12,7]],"date-time":"2020-12-07T19:02:13Z","timestamp":1607367733000},"page":"135-155","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":95,"title":["Necrotizing Soft Tissue Infections"],"prefix":"10.1016","volume":"35","author":[{"given":"Dennis L.","family":"Stevens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy E.","family":"Bryant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellie JC.","family":"Goldstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.idc.2020.10.004_bib1","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1308\/003588414X14055925058553","article-title":"Necrotising soft tissue infection in a UK metropolitan population","volume":"97","author":"Glass","year":"2015","journal-title":"Ann R Coll Surg Engl"},{"key":"10.1016\/j.idc.2020.10.004_bib2","first-page":"195","article-title":"Necrotizing fasciitis: epidemiology and clinical predictors for amputation","volume":"8","author":"Khamnuan","year":"2015","journal-title":"Int J Gen Med"},{"issue":"1","key":"10.1016\/j.idc.2020.10.004_bib3","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2169\/naika.105.99","article-title":"[Case report; a case of Lemierre's syndrome associated with necrotizing fasciitis and septic embolization]","volume":"105","author":"Suzuki","year":"2016","journal-title":"Nihon Naika Gakkai Zasshi"},{"key":"10.1016\/j.idc.2020.10.004_bib4","first-page":"1264283","article-title":"Severe sepsis associated with Lemierre's syndrome: a rare but life-threatening disease","volume":"2016","author":"Tawa","year":"2016","journal-title":"Case Rep Crit Care"},{"issue":"3","key":"10.1016\/j.idc.2020.10.004_bib5","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/00000658-190909000-00007","article-title":"VII. Large phagedenic ulcer of the abdomen","volume":"50","author":"Luckett","year":"1909","journal-title":"Ann Surg"},{"issue":"6","key":"10.1016\/j.idc.2020.10.004_bib6","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1097\/00000658-193112000-00001","article-title":"Bacterial synergism in disease processes: with a confirmation of the synergistic bacterial etiology of a certain type of progressive gangrene of the abdominal wall","volume":"94","author":"Meleney","year":"1931","journal-title":"Ann Surg"},{"issue":"6","key":"10.1016\/j.idc.2020.10.004_bib7","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1177\/0310057X1504300604","article-title":"Necrotising soft tissue infections: the effect of hyperbaric oxygen on mortality","volume":"43","author":"Devaney","year":"2015","journal-title":"Anaesth Intensive Care"},{"issue":"14","key":"10.1016\/j.idc.2020.10.004_bib8","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1056\/NEJMoa042683","article-title":"Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles","volume":"352","author":"Miller","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.idc.2020.10.004_bib9","series-title":"Cecil textbook of medicine","first-page":"1619","article-title":"Streptococcal Infections","author":"Stevens","year":"2000"},{"issue":"4","key":"10.1016\/j.idc.2020.10.004_bib10","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/cid\/ciw248","article-title":"Epidemiology of Invasive Group A Streptococcal Infections in the United States, 2005-2012","volume":"63","author":"Nelson","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.idc.2020.10.004_bib11","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1093\/cid\/cit282","article-title":"Pregnancy-related group a streptococcal infections: temporal relationships between bacterial acquisition, infection onset, clinical findings, and outcome","volume":"57","author":"Hamilton","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2020.10.004_bib12","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/clinids\/14.1.2","article-title":"Invasive group A streptococcus infections","volume":"14","author":"Stevens","year":"1992","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2020.10.004_bib13","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1001\/archinte.1985.00360060076010","article-title":"Streptococcal myositis","volume":"145","author":"Adams","year":"1985","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.1016\/j.idc.2020.10.004_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM198907063210101","article-title":"Reappearance of scarlet fever toxin A among streptococci in the Rocky Mountain West: severe group A streptococcal infections associated with a toxic shock-like syndrome","volume":"321","author":"Stevens","year":"1989","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.idc.2020.10.004_bib15","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.annepidem.2007.05.011","article-title":"Blunt trauma as a risk factor for group A streptococcal necrotizing fasciitis","volume":"17","author":"Nuwayhid","year":"2007","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.idc.2020.10.004_bib16","unstructured":"Stevens DL, Bryant AE. Severe group A streptococcal infections. In: Ferretti JJ, Stevens DL, Fischetti VA, editors. Streptococcus pyogenes: basic biology to clinical manifestations. NCBI e-book; Bookshelf ID: NBK333425; 2016:PMID: 26866227."},{"key":"10.1016\/j.idc.2020.10.004_bib17","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1056\/NEJM199601253340407","article-title":"Streptococcal infections in skin and soft tissues","volume":"334","author":"Bisno","year":"1996","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.idc.2020.10.004_bib18","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0002-9610(97)00297-3","article-title":"Limb salvage for streptococcal gangrene of the extremity","volume":"175","author":"Schurr","year":"1998","journal-title":"Am J Surg"},{"key":"10.1016\/j.idc.2020.10.004_bib19","series-title":"Streptococcus pyogenes : basic biology to clinical manifestations [Internet]","article-title":"Epidemiology of Streptococcus pyogenes","author":"Efstratiou","year":"2016"},{"issue":"3","key":"10.1016\/j.idc.2020.10.004_bib20","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/QCO.0000000000000160","article-title":"The roles of injury and nonsteroidal anti-inflammatory drugs in the development and outcomes of severe group A streptococcal soft tissue infections","volume":"28","author":"Bryant","year":"2015","journal-title":"Curr Opin Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2020.10.004_bib21","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/01.md.0000085060.63483.bb","article-title":"Assessing the relationship between the use of nonsteroidal antiinflammatory drugs and necrotizing fasciitis caused by group A streptococcus","volume":"82","author":"Aronoff","year":"2003","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"10.1016\/j.idc.2020.10.004_bib22","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.anorl.2013.08.005","article-title":"Possible role of anti-inflammatory drugs in complications of pharyngitis. A retrospective analysis of 163 cases","volume":"131","author":"Demeslay","year":"2014","journal-title":"Eur Ann Otorhinolaryngol Head Neck Dis"},{"issue":"1","key":"10.1016\/j.idc.2020.10.004_bib23","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1186\/s12879-016-1761-2","article-title":"Impact of anti-inflammatory drug consumption in peritonsillar abscesses: a retrospective cohort study","volume":"16","author":"Feasson","year":"2016","journal-title":"BMC Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2020.10.004_bib24","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s10096-016-2770-1","article-title":"Is there an association between prior anti-inflammatory drug exposure and occurrence of peritonsillar abscess (PTA)? A national multicenter prospective observational case-control study","volume":"36","author":"Lepelletier","year":"2017","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"9","key":"10.1016\/j.idc.2020.10.004_bib25","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1093\/infdis\/jit594","article-title":"Effects of selective and nonselective nonsteroidal anti-inflammatory drugs on antibiotic efficacy of experimental group A streptococcal myonecrosis","volume":"209","author":"Hamilton","year":"2014","journal-title":"J\u00a0Infect Dis"},{"issue":"6","key":"10.1016\/j.idc.2020.10.004_bib26","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.jmii.2011.04.012","article-title":"Ibuprofen worsens Streptococcus pyogenes soft tissue infections in mice","volume":"44","author":"Weng","year":"2011","journal-title":"J\u00a0Microbiol Immunol Infect"},{"issue":"2","key":"10.1016\/j.idc.2020.10.004_bib27","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/fcp.12336","article-title":"The role of nonsteroidal anti-inflammatory drugs intramuscular injection in the development and severity of deep soft tissue infection in mice","volume":"32","author":"Ture","year":"2017","journal-title":"Fundam Clin Pharmacol"},{"issue":"11","key":"10.1016\/j.idc.2020.10.004_bib28","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1086\/593016","article-title":"Muscle injury, vimentin expression, and nonsteroidal anti-inflammatory drugs predispose to cryptic group A streptococcal necrotizing infection","volume":"198","author":"Hamilton","year":"2008","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.idc.2020.10.004_bib29","first-page":"204","article-title":"Recurrent gas gangrene at a site of remote injury: localization due to circulating antitoxin","volume":"148","author":"Stevens","year":"1988","journal-title":"West J Med"},{"key":"10.1016\/j.idc.2020.10.004_bib30","series-title":"Cecil textbook of medicine","first-page":"2090","article-title":"Clostridial myonecrosis and other clostridial diseases","author":"Stevens","year":"1996"},{"issue":"4803","key":"10.1016\/j.idc.2020.10.004_bib31","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/S0140-6736(00)54169-5","article-title":"On the bacteriology of septic wounds","volume":"186","author":"Fleming","year":"1915","journal-title":"Lancet"},{"key":"10.1016\/j.idc.2020.10.004_bib32","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1128\/br.26.2_pt_1-2.177-274.1962","article-title":"The histotoxic clostridial infections of man","volume":"26","author":"MacLennan","year":"1962","journal-title":"Bacteriol Rev"},{"key":"10.1016\/j.idc.2020.10.004_bib33","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1001\/jama.1905.52510080026002g","article-title":"Anaerobic cellulitis","volume":"45","author":"Stewart","year":"1905","journal-title":"JAMA"},{"issue":"4206","key":"10.1016\/j.idc.2020.10.004_bib34","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1136\/bmj.2.4206.217","article-title":"Anaerobic cellulitis and gas gangrene","volume":"2","author":"Qvist","year":"1941","journal-title":"Br Med J"},{"issue":"7","key":"10.1016\/j.idc.2020.10.004_bib35","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1002\/1097-0142(19910401)67:7<1928::AID-CNCR2820670718>3.0.CO;2-9","article-title":"Clostridial bacteremia in cancer patients. A 12-year experience","volume":"67","author":"Bodey","year":"1991","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.idc.2020.10.004_bib36","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1093\/clinids\/12.2.286","article-title":"Spontaneous, nontraumatic gangrene due to Clostridium septicum","volume":"12","author":"Stevens","year":"1990","journal-title":"Rev Infect Dis"},{"issue":"11","key":"10.1016\/j.idc.2020.10.004_bib37","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1086\/508866","article-title":"Clostridium sordellii infection: epidemiology, clinical findings, and current perspectives on diagnosis and treatment","volume":"43","author":"Aldape","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2020.10.004_bib38","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1128\/CMR.16.3.451-462.2003","article-title":"Biology and pathogenesis of thrombosis and procoagulant activity in invasive infections caused by group A streptococci and Clostridium perfringens","volume":"16","author":"Bryant","year":"2003","journal-title":"Clin Microbiol Rev"},{"issue":"Pt 5","key":"10.1016\/j.idc.2020.10.004_bib39","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1099\/jmm.0.46390-0","article-title":"Clostridium perfringens phospholipase C-induced platelet\/leukocyte interactions impede neutrophil diapedesis","volume":"55","author":"Bryant","year":"2006","journal-title":"J\u00a0Med Microbiol"},{"issue":"3","key":"10.1016\/j.idc.2020.10.004_bib40","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1086\/514588","article-title":"Varying titres of neutralizing antibodies to streptococcal superantigens in different preparations of normal polyspecific immunoglobulin G (IVIG): implications for therapeutic efficacy","volume":"26","author":"Norrby-Teglund","year":"1998","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2020.10.004_bib41","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1093\/infdis\/168.1.232","article-title":"Superantigens associated with staphylococcal and streptococcal toxic shock syndromes are potent inducers of tumor necrosis factor beta synthesis","volume":"168","author":"Hackett","year":"1993","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.idc.2020.10.004_bib42","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1128\/iai.57.1.291-294.1989","article-title":"Toxic shock syndrome-associated staphylococcal and streptococcal pyrogenic toxins are potent inducers of tumor necrosis factor production","volume":"57","author":"Fast","year":"1989","journal-title":"Infect Immun"},{"issue":"12","key":"10.1016\/j.idc.2020.10.004_bib43","doi-asserted-by":"crossref","first-page":"5227","DOI":"10.1128\/iai.62.12.5227-5233.1994","article-title":"Superantigenic properties of the group A streptococcal exotoxin SpeF (MF)","volume":"62","author":"Norrby-Teglund","year":"1994","journal-title":"Infect Immun"},{"issue":"9","key":"10.1016\/j.idc.2020.10.004_bib44","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.1128\/iai.62.9.3731-3738.1994","article-title":"Similar cytokine induction profiles of a novel streptococcal exotoxin, MF, and pyrogenic exotoxins A and B","volume":"62","author":"Norrby-Teglund","year":"1994","journal-title":"Infect Immun"},{"key":"10.1016\/j.idc.2020.10.004_bib45","doi-asserted-by":"crossref","unstructured":"Kotb M, Majumdar G, Hackett SP, et\u00a0al. Temporal relationship of cytokine release by peripheral blood mononuclear cells stimulated by the streptococcal superantigen, pepM5. American Society for Microbiology 1992;New Orleans, LA.","DOI":"10.1128\/iai.61.4.1194-1201.1993"},{"issue":"12","key":"10.1016\/j.idc.2020.10.004_bib46","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1038\/nm1202-800","article-title":"An immunogenetic and molecular basis for differences in outcomes of invasive group A streptococcal infections","volume":"8","author":"Kotb","year":"2002","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.idc.2020.10.004_bib47","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1093\/infdis\/173.3.619","article-title":"Group A streptococcal bacteremia: the role of tumor necrosis factor in shock and organ failure","volume":"173","author":"Stevens","year":"1996","journal-title":"J\u00a0Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2020.10.004_bib48","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0092-8674(04)00057-1","article-title":"M\u00a0protein, a classical bacterial virulence determinant, forms complexes with fibrinogen that induce vascular leakage","volume":"116","author":"Herwald","year":"2004","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.idc.2020.10.004_bib49","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/SHK.0000000000000266","article-title":"Cardiac myocyte dysfunction induced by streptolysin O is membrane pore and calcium dependent","volume":"43","author":"Bolz","year":"2015","journal-title":"Shock"},{"key":"10.1016\/j.idc.2020.10.004_bib50","unstructured":"Stevens DL, Shelly MP, Stiller R, Villasenor-S.A., Bryant AE. Acute reversible cardiomyopathy in patients with streptococcal toxic shock syndrome. Proceedings of the XVIIth Lancefield International Symposium on Streptococci and Streptococcal Diseases, 179. Porto Heli, Greece, 2008. Ref Type: Abstract."},{"issue":"3","key":"10.1016\/j.idc.2020.10.004_bib51","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.cyto.2011.02.009","article-title":"Do cardiomyocytes mount an immune response to Group A Streptococcus?","volume":"54","author":"Li","year":"2011","journal-title":"Cytokine"},{"issue":"1","key":"10.1016\/j.idc.2020.10.004_bib52","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.cyto.2012.03.023","article-title":"Cardiac dysfunction in StrepTSS: group A streptococcus disrupts the directional cardiomyocyte-to-macrophage crosstalk that maintains macrophage quiescence","volume":"59","author":"Li","year":"2012","journal-title":"Cytokine"},{"issue":"12","key":"10.1016\/j.idc.2020.10.004_bib53","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1086\/504261","article-title":"Group A streptococcal myonecrosis: increased vimentin expression after skeletal-muscle injury mediates the binding of Streptococcus pyogenes","volume":"193","author":"Bryant","year":"2006","journal-title":"J\u00a0Infect Dis"},{"issue":"6","key":"10.1016\/j.idc.2020.10.004_bib54","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1093\/jnen\/60.6.588","article-title":"The expression of intermediate filament protein nestin as related to vimentin and desmin in regenerating skeletal muscle","volume":"60","author":"Vaittinen","year":"2001","journal-title":"J\u00a0Neuropathol Exp Neurol"},{"issue":"5","key":"10.1016\/j.idc.2020.10.004_bib55","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/00000658-199505000-00013","article-title":"Determinants of mortality for necrotizing soft-tissue infections","volume":"221","author":"McHenry","year":"1995","journal-title":"Ann Surg"},{"key":"10.1016\/j.idc.2020.10.004_bib56","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ijid.2015.04.021","article-title":"Red flags for necrotizing fasciitis: a case control study","volume":"36","author":"Alayed","year":"2015","journal-title":"Int J Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2020.10.004_bib57","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s11547-015-0575-4","article-title":"The role of contrast enhanced computed tomography in the diagnosis of necrotizing fasciitis and comparison with the Laboratory Risk Indicator for Necrotizing Fasciitis (LRINEC)","volume":"121","author":"Carbonetti","year":"2016","journal-title":"Radiol Med"},{"key":"10.1016\/j.idc.2020.10.004_bib58","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1056\/NEJM198406283102601","article-title":"Early recognition of potentially fatal necrotizing fasciitis. The use of frozen-section biopsy","volume":"310","author":"Stamenkovic","year":"1984","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.idc.2020.10.004_bib59","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1097\/00007611-199711000-00001","article-title":"Necrotizing fasciitis: improved survival with early recognition by tissue biopsy and aggressive surgical treatment","volume":"90","author":"Majeski","year":"1997","journal-title":"South Med J"},{"key":"10.1016\/j.idc.2020.10.004_bib60","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S0140-6736(94)90629-7","article-title":"Necrotising fasciitis due to group A streptococci in western Norway: incidence and clinical features","volume":"344","author":"Chelsom","year":"1994","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.idc.2020.10.004_bib61","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S1072-7515(00)00318-5","article-title":"A\u00a0simple model to help distinguish necrotizing fasciitis from nonnecrotizing soft tissue infection","volume":"191","author":"Wall","year":"2000","journal-title":"J\u00a0Am Coll Surg"},{"issue":"7","key":"10.1016\/j.idc.2020.10.004_bib62","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1097\/01.CCM.0000129486.35458.7D","article-title":"The LRINEC (Laboratory Risk Indicator for Necrotizing Fasciitis) score: a tool for distinguishing necrotizing fasciitis from other soft tissue infections","volume":"32","author":"Wong","year":"2004","journal-title":"Crit Care Med"},{"issue":"3","key":"10.1016\/j.idc.2020.10.004_bib63","doi-asserted-by":"crossref","first-page":"333","DOI":"10.5811\/westjem.2016.2.29069","article-title":"Inadequate sensitivity of laboratory risk indicator to rule out necrotizing fasciitis in the emergency department","volume":"17","author":"Burner","year":"2016","journal-title":"West J Emerg Med"},{"issue":"4","key":"10.1016\/j.idc.2020.10.004_bib64","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1177\/0310057X0903700416","article-title":"Application of the Laboratory Risk Indicator in Necrotising Fasciitis (LRINEC) score to patients in a tropical tertiary referral centre","volume":"37","author":"Holland","year":"2009","journal-title":"Anaesth Intensive Care"},{"issue":"6","key":"10.1016\/j.idc.2020.10.004_bib65","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.jpedsurg.2016.02.076","article-title":"Laboratory evaluation for pediatric patients with suspected necrotizing soft tissue infections: a case-control study","volume":"51","author":"Putnam","year":"2016","journal-title":"J\u00a0Pediatr Surg"},{"key":"10.1016\/j.idc.2020.10.004_bib66","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13017-016-0080-7","article-title":"Review of 58 patients with necrotizing fasciitis in the Netherlands","volume":"11","author":"van Stigt","year":"2016","journal-title":"World J Emerg Surg"},{"issue":"5","key":"10.1016\/j.idc.2020.10.004_bib67","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.jemermed.2012.09.039","article-title":"A\u00a0case of necrotizing fasciitis with a LRINEC score of zero: clinical suspicion should trump scoring systems","volume":"44","author":"Wilson","year":"2013","journal-title":"J\u00a0Emerg Med"},{"issue":"1","key":"10.1016\/j.idc.2020.10.004_bib68","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/SLA.0000000000002774","article-title":"Necrotizing soft tissue infection: diagnostic accuracy of physical examination, imaging, and LRINEC score: a systematic review and meta-analysis","volume":"269","author":"Fernando","year":"2019","journal-title":"Ann Surg"},{"issue":"6","key":"10.1016\/j.idc.2020.10.004_bib69","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0002-9610(85)80180-X","article-title":"Treatment of necrotizing soft tissue infections. The need for a new approach","volume":"149","author":"Freischlag","year":"1985","journal-title":"Am J Surg"},{"issue":"5","key":"10.1016\/j.idc.2020.10.004_bib70","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1445-2197.2012.06251.x","article-title":"Early diagnosis and treatment of necrotizing fasciitis can improve survival: an observational intensive care unit cohort study","volume":"83","author":"Bucca","year":"2013","journal-title":"ANZ J Surg"},{"issue":"1","key":"10.1016\/j.idc.2020.10.004_bib71","doi-asserted-by":"crossref","first-page":"22","DOI":"10.4103\/0974-2700.173868","article-title":"Early surgical intervention and its impact on patients presenting with necrotizing soft tissue infections: a single academic center experience","volume":"9","author":"Hadeed","year":"2016","journal-title":"J\u00a0Emerg Trauma Shock"},{"key":"10.1016\/j.idc.2020.10.004_bib72","unstructured":"Clinical and Laboratory Standards Institute. Performance Standards for antimicrobial susceptibility testing; 30th edition. CLSI Supplement M100 2020."},{"issue":"6","key":"10.1016\/j.idc.2020.10.004_bib73","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1006\/anae.1995.1032","article-title":"United States National Hospital Survey of anaerobic culture and susceptibility methods, II","volume":"1","author":"Goldstein","year":"1995","journal-title":"Anaerobe"},{"issue":"9","key":"10.1016\/j.idc.2020.10.004_bib74","doi-asserted-by":"crossref","first-page":"e01088-20","DOI":"10.1128\/AAC.01088-20","article-title":"The in\u00a0vitro activity of tedizolid compared to linezolid and five other antimicrobial agents against 332 anaerobic isolates including Bacteroides fragilis group spp., Prevotella, Porphyromonas and Veillonella spp","volume":"64","author":"Goldstein","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.idc.2020.10.004_bib75","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.anaerobe.2018.06.016","article-title":"In\u00a0vitro activity of eravacycline and comparator antimicrobials against 143 recent strains of Bacteroides and Parabacteroides species","volume":"52","author":"Goldstein","year":"2018","journal-title":"Anaerobe"},{"issue":"2","key":"10.1016\/j.idc.2020.10.004_bib76","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01992-17","article-title":"Comparative in\u00a0vitro activities of relebactam, imipenem, the combination of the two, and six comparator antimicrobial agents against 432 strains of anaerobic organisms, including imipenem-resistant strains","volume":"62","author":"Goldstein","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.idc.2020.10.004_bib77","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.anaerobe.2016.11.003","article-title":"Trends in antimicrobial resistance among Bacteroides species and Parabacteroides species in the United States from 2010-2012 with comparison to 2008-2009","volume":"43","author":"Snydman","year":"2017","journal-title":"Anaerobe"},{"issue":"3","key":"10.1016\/j.idc.2020.10.004_bib78","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1128\/CMR.00086-12","article-title":"Antianaerobic antimicrobials: spectrum and susceptibility testing","volume":"26","author":"Brook","year":"2013","journal-title":"Clin Microbiol Rev"},{"issue":"10","key":"10.1016\/j.idc.2020.10.004_bib79","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1086\/497143","article-title":"Practice guidelines for the diagnosis and management of skin and soft-tissue infections","volume":"41","author":"Stevens","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2020.10.004_bib80","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1093\/cid\/ciu296","article-title":"Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America","volume":"59","author":"Stevens","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2020.10.004_bib81","doi-asserted-by":"crossref","first-page":"2","DOI":"10.7547\/1030002","article-title":"2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections","volume":"103","author":"Lipsky","year":"2013","journal-title":"J\u00a0Am Podiatr Med Assoc"},{"issue":"12","key":"10.1016\/j.idc.2020.10.004_bib82","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1097\/00006454-199912000-00014","article-title":"Improved outcome of clindamycin compared with beta-lactam antibiotic treatment for invasive Streptococcus pyogenes infection","volume":"18","author":"Zimbelman","year":"1999","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"10.1016\/j.idc.2020.10.004_bib83","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1093\/cid\/ciu304","article-title":"Effectiveness of clindamycin and intravenous immunoglobulin, and risk of disease in contacts, in invasive group a streptococcal infections","volume":"59","author":"Carapetis","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.idc.2020.10.004_bib84","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1093\/cid\/ciu449","article-title":"Clinical efficacy of polyspecific intravenous immunoglobulin therapy in patients with streptococcal toxic shock syndrome: a comparative observational study","volume":"59","author":"Linner","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2020.10.004_bib85","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/infdis\/158.1.23","article-title":"The Eagle effect revisited: efficacy of clindamycin, erythromycin, and penicillin in the treatment of streptococcal myositis","volume":"158","author":"Stevens","year":"1988","journal-title":"J\u00a0Infect Dis"},{"issue":"11","key":"10.1016\/j.idc.2020.10.004_bib86","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1001\/archpedi.1979.02130110051007","article-title":"Sensitivity of group A streptococci to antibiotics. Prevalence of resistance to erythromycin in Japan","volume":"133","author":"Maruyama","year":"1979","journal-title":"Am J Dis Child"},{"issue":"3","key":"10.1016\/j.idc.2020.10.004_bib87","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1093\/jac\/dkm525","article-title":"Increasing telithromycin resistance among Streptococcus pyogenes in Europe","volume":"61","author":"Richter","year":"2008","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"9","key":"10.1016\/j.idc.2020.10.004_bib88","doi-asserted-by":"crossref","first-page":"3559","DOI":"10.1128\/AAC.48.9.3559-3562.2004","article-title":"Emergence of macrolide-resistant Streptococcus pyogenes strains in French children","volume":"48","author":"Bingen","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.idc.2020.10.004_bib89","doi-asserted-by":"crossref","first-page":"290","DOI":"10.4103\/0255-0857.136568","article-title":"Erythromycin-resistant genes in group A beta-haemolytic Streptococci in Chengdu, Southwestern China","volume":"32","author":"Zhou","year":"2014","journal-title":"Indian J Med Microbiol"},{"issue":"3","key":"10.1016\/j.idc.2020.10.004_bib90","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/INF.0000000000001442","article-title":"Macrolide and clindamycin resistance in group a streptococci isolated from children with pharyngitis","volume":"36","author":"DeMuri","year":"2017","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"10.1016\/j.idc.2020.10.004_bib91","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1128\/JCM.37.6.1727-1731.1999","article-title":"Characterization of antimicrobial resistance in Streptococcus pyogenes isolates from the San Francisco Bay area of northern California","volume":"37","author":"York","year":"1999","journal-title":"J\u00a0Clin Microbiol"},{"issue":"1","key":"10.1016\/j.idc.2020.10.004_bib92","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1128\/JCM.02208-10","article-title":"Emergence of erythromycin- and clindamycin-resistant Streptococcus pyogenes emm 90 strains in Hawaii","volume":"49","author":"Chen","year":"2011","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.idc.2020.10.004_bib93","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.jgar.2020.04.032","article-title":"Emerging erythromycin and clindamycin resistance in group A streptococcus: efficacy of linezolid and tedizolid in experimental necrotizing infection","volume":"22","author":"Bryant","year":"2020","journal-title":"J\u00a0Glob Antimicrob Resist"},{"key":"10.1016\/j.idc.2020.10.004_bib94","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1128\/AAC.31.2.312","article-title":"Comparison of single and combination antimicrobial agents for prevention of experimental gas gangrene caused by Clostridium perfringens","volume":"31","author":"Stevens","year":"1987","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.idc.2020.10.004_bib95","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1093\/infdis\/155.2.220","article-title":"Comparison of clindamycin, rifampin, tetracycline, metronidazole, and penicillin for efficacy in prevention of experimental gas gangrene due to Clostridium perfringens","volume":"155","author":"Stevens","year":"1987","journal-title":"J\u00a0Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2020.10.004_bib96","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jtv.2008.04.001","article-title":"Clindamycin-resistant Clostridium perfringens cellulitis","volume":"17","author":"Khanna","year":"2008","journal-title":"J\u00a0Tissue Viability"},{"issue":"4","key":"10.1016\/j.idc.2020.10.004_bib97","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1089\/sur.2011.109","article-title":"Spontaneous abscess of the anterior abdominal wall caused by Clostridium perfringens resistant to clindamycin","volume":"13","author":"Salido","year":"2012","journal-title":"Surg Infect (Larchmt )"},{"issue":"3","key":"10.1016\/j.idc.2020.10.004_bib98","first-page":"198","article-title":"Epidemiology of Clostridium species bacteremia in Calgary, Canada, 2000-2006","volume":"57","author":"Leal","year":"2008","journal-title":"J\u00a0Infect"},{"issue":"9","key":"10.1016\/j.idc.2020.10.004_bib99","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1128\/AAC.00355-08","article-title":"Increasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections: emerging resistance to carbapenems","volume":"52","author":"Liu","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.idc.2020.10.004_bib100","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.anaerobe.2014.05.015","article-title":"Antimicrobial susceptibility of clinical isolates of anaerobic bacteria in Ontario, 2010-2011","volume":"28","author":"Marchand-Austin","year":"2014","journal-title":"Anaerobe"},{"issue":"3","key":"10.1016\/j.idc.2020.10.004_bib101","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s00134-017-4683-6","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016","volume":"43","author":"Rhodes","year":"2017","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.idc.2020.10.004_bib102","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1093\/infdis\/157.2.272","article-title":"Lethal effects and cardiovascular effects of purified alpha- and theta-toxins from Clostridium perfringens","volume":"157","author":"Stevens","year":"1988","journal-title":"J\u00a0Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2020.10.004_bib103","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1001\/archsurg.138.3.272","article-title":"Hyperbaric oxygen for treating wounds: a systematic review of the literature","volume":"138","author":"Wang","year":"2003","journal-title":"Arch Surg"},{"issue":"4","key":"10.1016\/j.idc.2020.10.004_bib104","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.amjsurg.2005.01.012","article-title":"Hyperbaric oxygen as adjuvant therapy in the management of necrotizing fasciitis","volume":"189","author":"Jallali","year":"2005","journal-title":"Am J Surg"},{"issue":"11","key":"10.1016\/j.idc.2020.10.004_bib105","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1007\/s00104-012-2284-z","article-title":"[Hyperbaric oxygen therapy for necrotizing soft tissue infections: contra]","volume":"83","author":"Willy","year":"2012","journal-title":"Chirurg"},{"issue":"3","key":"10.1016\/j.idc.2020.10.004_bib106","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1089\/sur.2012.135","article-title":"Not just full of hot air: hyperbaric oxygen therapy increases survival in cases of necrotizing soft tissue infections","volume":"15","author":"Shaw","year":"2014","journal-title":"Surg Infect (Larchmt )"},{"key":"10.1016\/j.idc.2020.10.004_bib107","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1093\/clinids\/17.2.231","article-title":"Evaluation of hyperbaric oxygen therapy for treatment of experimental Clostridium perfringens infection","volume":"17","author":"Stevens","year":"1993","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.idc.2020.10.004_bib108","doi-asserted-by":"crossref","first-page":"e006995","DOI":"10.1136\/bmjopen-2014-006995","article-title":"Biomarkers of necrotising soft tissue infections: aspects of the innate immune response and effects of hyperbaric oxygenation-the protocol of the prospective cohort BIONEC study","volume":"5","author":"Hansen","year":"2015","journal-title":"BMJ Open"},{"issue":"4","key":"10.1016\/j.idc.2020.10.004_bib109","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0891-5520(05)70324-X","article-title":"The toxic shock syndromes","volume":"10","author":"Stevens","year":"1996","journal-title":"Infect Dis Clin North Am"},{"issue":"11","key":"10.1016\/j.idc.2020.10.004_bib110","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1007\/s00134-017-4786-0","article-title":"Immunoglobulin G for patients with necrotising soft tissue infection (INSTINCT): a randomised, blinded, placebo-controlled trial","volume":"43","author":"Madsen","year":"2017","journal-title":"Intensive Care Med"},{"issue":"7","key":"10.1016\/j.idc.2020.10.004_bib111","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1093\/cid\/ciw871","article-title":"Impact of intravenous immunoglobulin on survival in necrotizing fasciitis with vasopressor-dependent shock: a propensity score-matched analysis from 130\u00a0US Hospitals","volume":"64","author":"Kadri","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2020.10.004_bib112","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1086\/376630","article-title":"Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial","volume":"37","author":"Darenberg","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.idc.2020.10.004_bib113","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1093\/cid\/ciy401","article-title":"Polyspecific intravenous immunoglobulin in clindamycin-treated patients with streptococcal toxic shock syndrome: a systematic review and meta-analysis","volume":"67","author":"Parks","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2020.10.004_bib114","article-title":"Risk factors and predictors of mortality in streptococcal necrotizing soft-tissue infections: a multicenter prospective study","author":"Bruun","year":"2020","journal-title":"Clin Infect Dis"}],"container-title":["Infectious Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552020300830?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552020300830?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:17:52Z","timestamp":1760195872000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891552020300830"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":114,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S0891552020300830"],"URL":"https:\/\/doi.org\/10.1016\/j.idc.2020.10.004","relation":{},"ISSN":["0891-5520"],"issn-type":[{"value":"0891-5520","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Necrotizing Soft Tissue Infections","name":"articletitle","label":"Article Title"},{"value":"Infectious Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idc.2020.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}